effects on postoperative pain after injection of dexmedetomidine on the surgical site in maxillofacial trauma cases
Phase 3
- Conditions
- Health Condition 1: S024- Fracture of malar, maxillary and zygoma bonesHealth Condition 2: S026- Fracture of mandibleHealth Condition 3: S023- Fracture of orbital floor
- Registration Number
- CTRI/2023/01/049264
- Lead Sponsor
- AIIMS Patma
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
maxillofacial trauma cases with a VAS score greater than 4
patients consenting to participate in the study
patients with ASA1 and ASA2
Exclusion Criteria
patients who have known hypersensitivity to lignocaine, dexmedetomidine, fentanyl
pregnancy, lactating mothers
patients who have a hepatic, renal, or cardiopulmonary abnormality
patients with a significant history of head injury
patients undergoing conservative management for the maxillofacial trauma
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method